Larvol Delta - An-openlabel-clinical-study-to-evaluate-the-safety-and-pharmacodynamics-of-QH103-cell-injection-CD19-CART-cells-in-the-treatment-of-relapsedrefractory-autoimmune-diseases

QH103 - Beijing Qinghui Liannuo Biotechnology

https://www.chictr.org.cn/showproj.html?proj=250386

Jan 21, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next